Neuropsychopharmacology
- Childhood family environment and μ-opioid receptor availability in vivo in adulthood5 months ago
- Neuroactive steroid biosynthesis during pregnancy predicts future postpartum depression: a role for the 3α and/or 3β-HSD neurosteroidogenic enzymes?5 months ago
- Endocannabinoid contributions to the perception of socially relevant, affective touch in humans6 months ago
- Correction: Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET study6 months ago
- Early postnatal NMDA receptor ablation in cortical interneurons impairs affective state discrimination and social functioning6 months ago
- Polygenic overlap with granulocyte counts identifies novel loci for clozapine metabolism and clozapine-induced agranulocytosis6 months ago
- Examining memory reconsolidation as a mechanism of nitrous oxide’s antidepressant action6 months ago
Journal of Psychopharmacology
- Mechanisms of psilocybin on the treatment of posttraumatic stress disorder9 months ago
- Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis9 months ago
- Towards precision dosing in psychiatry: Population pharmacokinetics meta-modelling of clozapine and lithium9 months ago
- Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat9 months ago
- Aspirin may be more suitable for patients with major depression: Evidence from two-sample Mendelian randomization analysis9 months ago
- Optimizing the individual dosing of paroxetine in major depressive disorder with therapeutic drug monitoring10 months ago
- Serotonin release by parachloroamphetamine in rats with high and low sociability: High prefrontal release capacity in sociable females10 months ago
European Neuropsychopharmacology
- The post COVID era in mental health systems: Better together9 months ago
- Towards a consensus roadmap for a new diagnostic framework for mental disorders9 months ago
- Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses9 months ago
- Structural connectivity of dopaminergic pathways in major depressive disorder: An ultra-high resolution 7-Tesla diffusion MRI study9 months ago
- A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder9 months ago
- Lung function decline in people with serious mental illness: A call to action9 months ago
- Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker9 months ago